Home ›
Trademark Categories ›
Pharmaceuticals ›
2013 ›
CR ›
CROFFESTRA
Trademark search for:
CROFFESTRA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2013-02-25 — Application filed
2013-02-28 — Application filed
2013-03-04 — Application filed
2013-06-09 — Assigned to examiner
2013-06-15 — Approved for pub - principal register
2013-07-03 — Notification of notice of publication e-mailed
2013-07-23 — Published for opposition
2013-07-23 — Official gazette publication confirmation e-mailed
2013-09-17 — Noa e-mailed - sou required from applicant
2014-01-22 — Sou teas extension received
2014-01-22 — Sou extension 1 filed
2014-02-17 — Case assigned to intent to use paralegal
2014-02-18 — Sou extension 1 granted
2014-02-19 — Notice of approval of extension request e-mailed
2014-09-17 — Sou teas extension received
2014-09-17 — Sou extension 2 filed
2014-09-18 — Sou extension 2 granted
2014-09-19 — Notice of approval of extension request e-mailed
2015-03-17 — Sou teas extension received
2015-03-17 — Sou extension 3 filed
2015-03-25 — Sou extension 3 granted
2015-03-26 — Notice of approval of extension request e-mailed
2015-10-19 — Application abandoned
2015-10-19 — Application abandoned
2015-10-19 — Final status recorded
Owner Information
Glenmark Pharmaceuticals Limited
Mumbai IN
Glenmark Pharmaceuticals Limited
Mumbai IN
Correspondent
HOWARD J. SHIRE KENYON & KENYON LLP 1 BROADWAY NEW YORK, NY 10004-1007 UNITED STATES
Filing Details
Filing Date:
2013-02-25
Status Date:
2015-10-19
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.